Experimental cancer drug BGB-3245 studied in early trial
Disease control
Terminated
This early-phase study tested an experimental drug called BGB-3245 (brimarafenib) in 109 people with advanced solid tumors that had not responded to standard treatments. The drug is designed to block certain proteins that help cancer grow. The main goals were to check safety, fin…
Phase: PHASE1 • Sponsor: MapKure, LLC • Aim: Disease control
Last updated Jun 26, 2026 15:30 UTC